Form 13-F position report

ORAMED PHARM INC

Reported by THE BANK OF NEW YORK MELLON CORPORATION

ORMP CUSIP 68403P203 Manager CIK 0001390777

Reported 0 shares, down 97,214 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2022
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 5 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 1170000
2022-03-31 841000
2022-06-30 0
2026-06-30 381217
2026-09-30 370121

Quarterly position history

How this manager's reported quarter-end position changed over time.

5 quarters
Quarterly reported position history for ORAMED PHARM INC held by THE BANK OF NEW YORK MELLON CORPORATION.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Unchanged 79,255 0 (0.0%) < 0.01% $370,121 2026-11-05
Q2 2026 New 79,255 +79,255 (0.0%) < 0.01% $381,217 2026-08-06
Q2 2022 Reduced 0 -97,214 (-100.0%) 0 $0 2022-08-15
Q1 2022 Added 97,214 +15,296 (18.7%) < 0.01% $841,000 2022-05-11
Q4 2021 Added 81,918 +11,772 (16.8%) < 0.01% $1,170,000 2022-02-11
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

114 managers reported ORAMED PHARM INC for Q2 2022.

Managers reporting ORAMED PHARM INC in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
MORGAN STANLEY Added 686,591 +92,746 < 0.01% $3,144,000 35 qtrs
TWO SIGMA ADVISERS LP Added 681,800 +19,800 < 0.01% $3,123,000 3 qtrs
CITADEL ADVISORS LLC Added 648,833 +463,354 < 0.01% $2,972,000 8 qtrs
TWO SIGMA INVESTMENTS LP Added 639,557 +88,601 < 0.01% $2,929,000 3 qtrs
MILLENNIUM MANAGEMENT LLC Added 580,383 +216,823 < 0.01% $2,658,000 12 qtrs
RENAISSANCE TECHNOLOGIES LLC New 359,697 +359,697 < 0.01% $1,647,000 3 qtrs
JPMorgan Chase & Co Added 336,549 +319,053 < 0.01% $1,541,000 5 qtrs
BANK OF MONTREAL New 249,200 +249,200 < 0.01% $1,348,000 1 qtr
Ergoteles LLC New 224,700 +224,700 0.03% $1,029,000 3 qtrs
BlackRock Inc Reduced 139,052 -1,691,114 < 0.01% $637,000 17 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 15, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.